Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
576.77 USD539.09 USD675.94 USD
+28%
539.09 USDCurrent price is 28% above the base model value.
R
HealthcareBiotechnologyUnited States
REGN.US · Regeneron Pharmaceuticals, Inc.
NMS · US · USD
Latest price690.03 USD
30D+3.3%
Vs. base value+28%
Research summary
REGN.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +2.09% YoY. Current price is about 690 USD, while the model base case is about 539 USD; the current price sits +28% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue-
Net income5B USD
Free cash flow5B USD
Operating cash flow5B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:22
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price690.03 USD
Base value539.09 USD
Vs. base+28%
Price date2026/04/28
576.77 USD539.09 USD658.54 USD
+28%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
589.15 USD632.83 USD658.54 USD
+9.04%
632.83 USDCurrent price is close to the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth1.3%
Current price implies roughly 1.3% annualized FCF growth.
1.3%Current price implies roughly 1.3% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
312.94 USD312.94 USD312.94 USD
+120%
312.94 USDCurrent price is 120.5% above the base model value.
Updated: 2026/04/29 07:22
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 10
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | - | 5B USD | 5B USD | 41.48 |
| 2024/12/30 | Annual | - | 4B USD | 4B USD | 38.34 |
| 2023/12/30 | Annual | - | 4B USD | 5B USD | 34.77 |
| 2022/12/30 | Annual | - | 4B USD | 5B USD | 38.22 |
| 2021/12/30 | Annual | - | 8B USD | 7B USD | 71.97 |
Ad placement